Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 53
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Acta Cardiol ; 71(2): 191-7, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27090041

RESUMEN

OBJECTIVE: Galectin-3, reflecting cardiac fibrosis, is a promising biomarker in early detection of heart failure with preserved ejection fraction (HFpEF). We aimed to clarify the clinical utility of galectin-3 levels in the diagnosis of HFpEF and to compare galectin-3 with N-terminal pro-brain-type natriuretic peptide (NT-proBNP) levels. METHODS AND RESULTS: The study included 44 HFpEF patients (mean age 60 ± 6.78 years, 24 men) and 38 control subjects (mean age 57 ± 8.98 years, 20 men). Galectin-3 and NT-proBNP levels were assessed by the ELISA kits. The receiver operating characteristics (ROC) curve was used to examine the diagnostic performance of galectin-3 and NT-proBNP in HFpEF. Galectin-3 and NT-proBNP levels were significantly increased in patients with HFpEF compared to controls [5.35 ng/ml (0.86 ­ 14.90) vs 0.51 ng/ml (0.15 ­ 1.71) P < 0.0001, 617.75 ± 271.30 pg/ml vs 66.35 ± 54.01 pg/ml P < 0.0001, respectively]. Galectin-3 correlated with NT-proBNP, left atrial volume index, left ventricular mass index, and E/E' (r = 0.90, P < 0.0001; r = 0.75, P = 0.0001; r = 0.86, P = 0.0001; r = 0.80, P = 0.0001; respectively). The area under the ROC curve was 0.98 for galectin-3 and 1.0 for NT-proBNP. CONCLUSIONS: Our results support that, in addition to NT-proBNP, galectin-3 is also a valuable biomarker for the diagnosis of patients with HFpEF.


Asunto(s)
Galectina 3/sangre , Insuficiencia Cardíaca/sangre , Péptido Natriurético Encefálico/sangre , Fragmentos de Péptidos/sangre , Anciano , Biomarcadores/sangre , Femenino , Insuficiencia Cardíaca/diagnóstico , Insuficiencia Cardíaca/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Curva ROC , Reproducibilidad de los Resultados , Volumen Sistólico , Función Ventricular Izquierda
2.
Asian Pac J Allergy Immunol ; 33(4): 289-95, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26708392

RESUMEN

BACKGROUND: There is an association between adiponectin (APN) and asthma. However, the mechanisms underlying this association is unclear. APN is a predominantly anti-inflammatory protein with possible signalling activity in the lung that can be secreted by Epicardial Adipose Tissue (EAT). Our hypothesis is that serum APN levels may be directly and simply related to the amount of EAT accumulation, particularly when it is expressed as thickness in children with asthma. OBJECTIVE: The aim of this study was to investigate whether serum adiponectin (APN) and epicardial adipose tissue thickness (EATT) have an effect in non-obese children with asthma and in healthy non-asthmatic children, and analyze their relationships with clinical outcomes. METHODS: 68 children diagnosed with asthma (20 girls/48 boys) who had applied at the pediatric allergy and clinical immunology clinic of the hospital were included in this cross-sectional, observational study. The age-matched control group included 39 healthy children (18 girls/21 boys). EATT was measured by transthoracic echocardiography. The serum APN levels were also checked. Statistical analysis was performed by using independent sample t-test and Spearman correlation analyses. RESULTS: The mean age of the asthma group was 10.2 ± 2.7 years, and the average EATT was found to be 5.1 ± 0.1 mm. The mean age of the control group was 10.5 ± 2.8 years, and the average EATT was found to be 5.1 ± 0.7 mm. The EATT of the asthma group was found to be significantly higher (p < 0.001) in study group. In the asthma group the APN was 10.0 ± 5.3 mg/L, and in the control group the APN was 15.8 ± 10.5 mg/L (p < 0.001). We found that APN was significantly negatively correlated with EATT (r = -0.266, p = 0.006) in asthma and control groups. CONCLUSION: EATT is associated with non-obese asthmatic children. High EATT may be related with high release of pro-inflammatory cytokine and low release of APN. Low levels of APN may be related to low anti-inflammatory effects. Therefore, high EATT and low levels of APN may indicate pro-inflammantory profiles in non-obese asthmatic children.


Asunto(s)
Adiponectina/sangre , Tejido Adiposo/patología , Asma/patología , Pericardio/patología , Adolescente , Asma/sangre , Niño , Estudios Transversales , Femenino , Humanos , Masculino
3.
Clin Lab ; 60(11): 1909-20, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25648034

RESUMEN

BACKGROUND: The aim of this study was to evaluate the serum soluble CD40 ligand (sCD40L) levels, serum uroten- sin II levels, and serum leptin levels as an indirect indicator of endothelial dysfunction, inflammation, and atherosclerosis at the microvascular level, and the comparison of those values with those of the control group with a nor- mal coronary flow pattern. METHODS: The study included 35 consecutive patients (17 women, 18 men; average age: 51.20 ± 10.93 years) in our hospital who underwent coronary angiography due to objective myocardial ischemia and in whom slow coronary flow was detected. The control group included 34 consecutive patients with normal coronary flow pattern (18 women, 16 men; average age: 54.59 ± 12.40 years). The coronary flow rates of all patients and control subjects were documented by the thrombolysis in myocardial infarction (TIMI) frame count. Serum sCD40L concentrations, serum urotensin II concentrations and serum leptin concentrations were measured by an enzyme-linked immunosorbent assay method using commercially available kits. RESULTS: The corrected TIMI frame count for LAD, Cx, RCA, and mean TIMI frame count were significantly higher in patients with slow coronary flow (SCF), compared to subjects with normal coronary flow (43.8 ± 1.7 vs. 17.7 ± 4.7, p < 0.001; 27.9 ± 6.9 vs. 11.9 ± 4.8, p < 0.001; 25.4 ± 8.4 vs. 11.1 ± 3.1, p < 0.001; and 32.3 ± 6.4 vs. 13.7 ± 5, p < 0.001, respectively). The serum soluble CD40 ligand and serum urotensin II levels were significantly higher in the slow coronary flow group compared to the control group (12.00 ± 5.43 ng/mL--6.49 ± 5.03 ng/mL, p < 0.001; and 50.94 ± 34.28 pg/mL--26.91 ± 11.52 pg/mL, p < 0.001, respectively). In addition, there was no statistically significant difference between the slow coronary flow group and the control group with regard to serum leptin levels and hs-CRP levels (both p > 0.05). CONCLUSIONS: This study suggests that soluble CD40 ligand and urotensin II likely play a role in the pathogenesis of slow coronary flow.


Asunto(s)
Ligando de CD40/sangre , Circulación Coronaria , Fenómeno de no Reflujo/sangre , Receptores Acoplados a Proteínas G/sangre , Adulto , Biomarcadores/sangre , Estudios de Casos y Controles , Angiografía Coronaria , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Leptina/sangre , Masculino , Persona de Mediana Edad , Fenómeno de no Reflujo/diagnóstico , Fenómeno de no Reflujo/fisiopatología , Estudios Prospectivos , Regulación hacia Arriba
4.
J Appl Toxicol ; 33(5): 364-9, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-21989851

RESUMEN

The aim of this study was to investigate the effects of onion (Allium cepa) extracts (ACE) on doxorubicin (DOX)-induced apoptosis in aortic endothelial cells. The rats in the ACE-pretreated group were given a daily dose of 1 ml ACE for 14 days. To induce aortic endothelial cell apoptosis, DOX (30 mg kg(-1) body weight) was injected intraperitoneally by a single dose and the rats were sacrificed after 48 h. To date, no such studies have been performed on antiapoptotic potential of ACE on DOX-induced apoptosis in aortic endothelial cells. Our data indicate a significant reduction in the activity of in situ identification of apoptosis using terminal dUTP nick end-labeling in aortic endothelial cells of the DOX-treated group with ACE therapy. DOX-treated with ACE groups showed a significant decrease in malondialdehyde levels and increased levels of glutathione in comparison with the DOX-treated group. Data from our study show that prevention of endothelial cell apoptosis by ACE may contribute to the restoration of aortic endothelial dysfunction that is associated with DOX treatment.


Asunto(s)
Apoptosis/efectos de los fármacos , Doxorrubicina/toxicidad , Células Endoteliales/efectos de los fármacos , Cebollas/química , Extractos Vegetales/farmacología , Animales , Antioxidantes/farmacología , Aorta/citología , Aorta/efectos de los fármacos , Glutatión/metabolismo , Etiquetado Corte-Fin in Situ , Masculino , Malondialdehído/metabolismo , Ratas , Ratas Sprague-Dawley
5.
J Appl Toxicol ; 33(3): 202-8, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21996788

RESUMEN

The aim of this study was to investigate the antioxidant and anti-apoptotic effects of onion (Allium cepa) extracts (ACE) on doxorubicin (DOX)-induced cardiotoxicity. The rats in the ACE-pretreated group were given a daily dose of 1 ml ACE for 14 days. To induce cardiotoxicity, DOX (30 mg kg(-1) body weight) was injected intraperitoneally by a single dose and the rats were sacrificed after 48 h. To date, no such studies have been performed on the cardioprotective and anti-apoptotic potential of ACE on DOX-induced cardiotoxicity. Our data indicate a significant reduction in the activity of in situ identification of apoptosis using terminal dUTP nick end-labeling in cardiomyocytes of the DOX-treated group with ACE therapy. The DOX-treated with ACE groups showed a significant decrease in malondialdehyde levels, and increased activities of superoxide dismutase, glutathione and glutathione peroxidase in comparison with the DOX-treated group. Creatine kinase, creatine kinase MB, lactate dehydrogenase activities and cardiac troponin I levels were significantly decreased in the DOX + ACE group in comparison with the DOX group. These biochemical and histological disturbances were effectively attenuated on pretreatment with ACE. The present study showed that ACE may be a suitable cardioprotector against toxic effects of DOX.


Asunto(s)
Antibióticos Antineoplásicos/toxicidad , Antioxidantes/farmacología , Apoptosis/efectos de los fármacos , Doxorrubicina/toxicidad , Cardiopatías/tratamiento farmacológico , Cebollas/química , Extractos Vegetales/farmacología , Animales , Antibióticos Antineoplásicos/antagonistas & inhibidores , Doxorrubicina/antagonistas & inhibidores , Antagonismo de Drogas , Corazón/efectos de los fármacos , Cardiopatías/inducido químicamente , Cardiopatías/patología , Masculino , Miocardio/patología , Miocitos Cardíacos/efectos de los fármacos , Miocitos Cardíacos/patología , Ratas , Ratas Sprague-Dawley
6.
Turk Kardiyol Dern Ars ; 40(1): 55-8, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22395376

RESUMEN

A 67-year-old male patient with an eight-month history of operation for mitral valve repair and secundum atrial septal defect (ASD) presented with complaints of fatigue and shortness of breath. Transthoracic echocardiography showed a residual ASD resulting from separation of a pericardial patch. Qp/Qs rate was 3.2. The diameter of the residual defect measured by transesophageal echocardiography was 18 mm. During right heart catheterization, pulmonary artery pressure was estimated to be 50 mmHg. Using the percutaneous method accompanied by transesophageal echocardiography guidance, the residual defect was successfully closed with a 21-mm Occlutech Figulla device. Postprocedural echocardiographic control showed no leaks. The patient was discharged with 300 mg/day aspirin treatment.


Asunto(s)
Defectos del Tabique Interatrial/cirugía , Complicaciones Posoperatorias/cirugía , Dispositivo Oclusor Septal , Anciano , Diagnóstico Diferencial , Disnea/etiología , Fatiga/etiología , Defectos del Tabique Interatrial/complicaciones , Defectos del Tabique Interatrial/diagnóstico por imagen , Humanos , Masculino , Prolapso de la Válvula Mitral/cirugía , Complicaciones Posoperatorias/diagnóstico por imagen , Ultrasonografía
7.
Pacing Clin Electrophysiol ; 34(11): 1511-4, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21797894

RESUMEN

BACKGROUND: It has long been speculated that mobile phones may interact with the cardiac devices and thereby cardiovascular system may be a potential target for the electromagnetic fields emitted by the mobile phones. Therefore, the present study was designed to test possible effects of radiofrequency waves emitted by digital mobile phones on cardiac autonomic modulation by short-time heart rate variability (HRV) analysis. METHODS AND RESULTS: A total of 20 healthy young subjects were included to the study. All participants were rested in supine position at least for 15 minutes on a comfortable bed, and then time and frequency domain HRV parameters were recorded at baseline in supine position for 5 minutes. After completion of baseline records, by using a mobile GSM (Global System for Mobile Communication) phone, HRV parameters were recorded at turned off mode, at turned on mode, and at calling mode over 5 minutes periods for each stage. CONCLUSION: Neither time nor frequency domain HRV parameters altered significantly during off mode compare to their baseline values. Also, neither time nor frequency domain HRV parameters altered significantly during turned on and calling mode compared to their baseline values. Short-time exposure to electromagnetic fields emitted by mobile phone does not affect cardiac autonomic modulation in healthy subjects.


Asunto(s)
Carga Corporal (Radioterapia) , Teléfono Celular , Electrocardiografía , Sistema de Conducción Cardíaco/efectos de la radiación , Frecuencia Cardíaca/efectos de la radiación , Microondas , Recuento Corporal Total , Adulto , Sistema de Conducción Cardíaco/fisiología , Frecuencia Cardíaca/fisiología , Humanos , Masculino , Dosis de Radiación , Valores de Referencia , Medición de Riesgo
8.
Tohoku J Exp Med ; 225(1): 13-16, 2011 09.
Artículo en Inglés | MEDLINE | ID: mdl-21836390

RESUMEN

Slow coronary flow (SCF) is characterized by delayed opacification of coronary arteries during coronary angiography and is associated with myocardial perfusion abnormalities, ischemia or myocardial infarction. We hypothesized that SCF could be a part of systemic circulatory abnormalities. Therefore, the present study was conducted to investigate whether cerebral blood flow velocity is altered in patients with SCF. The study included 16 patients suffering from chest pain with angiographically proven SCF and 16 subjects suffering from atypical chest pain with angiographically normal coronary flow. All study subjects were selected among those who undergone routine cardiac catheterization. SCF was defined based on thrombolysis in myocardial infarction frame count that reflects coronary artery flow. Thrombolysis in myocardial infarction frame count was significantly higher in patients with SCF than those with normal coronary flow. The average peak systolic, end diastolic and mean flow velocities of the middle cerebral artery were measured and recorded in both groups by transcranial Doppler ultrasonography. Baseline demographic properties were similar in both groups. Echocardiographic parameters were also similar in patients with SCF and those with normal coronary flow. In contrast, both right and left middle cerebral artery peak systolic, end diastolic and mean flow velocities were significantly lower in patients with SCF than those with normal coronary flow. We conclude that cerebral blood flow velocity is significantly lower in patients with SCF. SCF phenomenon may reflect a part of impaired systemic circulation.


Asunto(s)
Circulación Cerebrovascular/fisiología , Vasos Coronarios/fisiopatología , Fenómeno de no Reflujo/complicaciones , Anciano , Angiografía , Velocidad del Flujo Sanguíneo/fisiología , Ecocardiografía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Ultrasonografía Doppler Transcraneal
9.
Heart Vessels ; 24(2): 138-41, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19337798

RESUMEN

Accumulating data suggest that activity of matrix metalloproteinases (MMPs) is increased in aortic dissection, and in thoracic and abdominal aneurysms. In the present study we sought to determine circulating stromelysin (MMP-3) concentration and its relationship with hypertension-induced aortic root dilatation. The study population included 42 patients with essential hypertension. The subjects were divided into two groups according to echocardiographically measured aortic diameter as those with aortic dilatation (n = 22) and without aortic root dilatation (n = 20). Plasma concentration of MMP-3 was determined by one-step sandwich enzyme immunoassay (EIA) method and compared in both groups. Baseline demographic properties were similar in both groups. Plasma stromelysin (MMP-3) level was significantly higher in patients with aortic dilatation than those without aortic dilatation (5.2 +/- 2.3 vs 3.3 +/- 1.9 ng/ml; P = 0.007). In conclusion, we found that circulating stromelysin (MMP-3) concentration was elevated in hypertension-induced aortic root dilatation.


Asunto(s)
Enfermedades de la Aorta/enzimología , Hipertensión/enzimología , Metaloproteinasa 3 de la Matriz/sangre , Anciano , Enfermedades de la Aorta/diagnóstico por imagen , Enfermedades de la Aorta/etiología , Dilatación Patológica , Ecocardiografía Doppler en Color , Ecocardiografía Doppler de Pulso , Femenino , Humanos , Hipertensión/complicaciones , Hipertensión/diagnóstico por imagen , Técnicas para Inmunoenzimas , Masculino , Persona de Mediana Edad , Regulación hacia Arriba
10.
Neurosciences (Riyadh) ; 14(1): 14-8, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21048567

RESUMEN

OBJECTIVE: To investigate the P wave duration and P wave dispersion in stroke patients, and to compare those with healthy subjects. METHODS: We measured maximum and minimum P wave durations, and dispersion on the 12-lead surface ECG in 67 consecutive patients with first ever-acute ischemic stroke and 58 controls at the neurology wards of the Medical School, Duzce, Turkey, between May 2005 and October 2006. The subjects were not included if there were a history of atrial fibrillation, cardiac problem, and using drugs related to cardiovascular diseases or psychiatric problems. RESULTS: P wave durations and dispersion were similar in stroke patients and controls. The correlation analysis revealed a positive relation between age and Pmin duration (p=0.03). The mean Pmin values were 63.85+/-22.55 for male and 76.43+/-26.84 for female patients, and this difference was statistically significant (p=0.04). The correlations between P wave durations, and the presence of risk factors, the stroke outcome scales, and death of patient within 6 months were not statistically significant. CONCLUSION: Although there were some previous reports on ECG changes including P waves in acute stroke, we found that P wave durations and dispersion were similar in acute stroke patients and controls. This may be related to the patient selection criteria of this study, as we did not include patients with any previous cardiac abnormality. We concluded that the autonomic nervous system dysfunctions causing cardiac abnormalities in stroke need more investigation.

12.
J Electrocardiol ; 40(2): 203-6, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16631193

RESUMEN

Isolated coronary ectatic but otherwise normal epicardial coronary arteries are an infrequent angiographic finding. We sought to determine whether coronary artery ectasia (CAE) may alter QT-interval duration and dispersion. The study population consisted of 24 patients with isolated CAE and otherwise normal epicardial coronary arteries (group 1) and sex- and age-matched subjects with atypical chest pain and otherwise normal coronary flow (group 2). Both groups underwent a routine standard 12-lead surface electrocardiogram recorded at 50 mm/s during rest. QT dispersion (QTd), corrected QT (QTc), and corrected QT dispersion (QTcd) were calculated. Distribution of sex, age, body mass index, and cardiac risk factors were similar in the 2 groups. Mean heart rate was similar in the 2 groups (74 +/- 10 vs 70 +/- 7, P > .05). In group 1, QTd, QTcd, and QTc were significantly higher than those of group 2 (QTd, 40 +/- 17 vs 29 +/- 10 milliseconds [P < .05]; QTcd, 43 +/- 19 vs 30 +/- 10 milliseconds [P < .05]; QTc, 410 +/- 21 vs 397 +/- 19 milliseconds [P < .05]). In conclusion, CAE was found to be associated with prolonged QT interval and increased QTd. Microvascular dysfunction and/or ischemia may be responsible mechanisms.


Asunto(s)
Aneurisma Coronario/diagnóstico , Electrocardiografía/métodos , Síndrome de QT Prolongado/diagnóstico , Isquemia Miocárdica/diagnóstico , Disfunción Ventricular Izquierda/diagnóstico , Angiografía Coronaria , Dilatación Patológica/diagnóstico , Humanos , Persona de Mediana Edad
13.
Angiology ; 58(4): 408-12, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17652223

RESUMEN

The slow coronary flow (SCF) phenomenon is often considered to be an incidental angiographic finding; however, several reports have shown it to be associated with cardiac events. In this study we aimed to assess P-wave duration and dispersion (PWD) in patients with SCF and to compare it with that of healthy subjects. Thus, 40 patients with angiographically proven SCF and otherwise normal coronary arteries (group 1) and 36 sex-age-matched healthy subjects (group 2) were included in this study. A 12-lead surface ECG, recorded at a paper speed of 50-mm/s and 2 mV/cm standardization, was obtained from each subject. P-wave duration was measured manually by use of a caliper. The difference between the maximum (Pmax) and minimum P (Pmin)-wave duration was calculated and defined as PWD. All subjects had undergone echocardiographic examination to exclude valvular disorders and wall motion abnormalities. There was no significant difference between the 2 groups in demographies of age, sex, heart rate, or blood pressure. Maximum P-wave duration and PWD were significantly higher in group 1 than in group 2 (120 +/-7 vs 115 +/-5, p = 0.003; 44 +/-12 vs 38 +/-9, p = 0.01, respectively). However, there was no significant difference in Pmin duration (75 +/-9 vs 78 +/-7, p = 0.4). In conclusion; SCF and otherwise normal epicardial coronary artery was found to be associated with prolonged P-wave duration and increased PWD. This may result from microvascular ischemia and/or altered autonomic control of cardiovascular system observed in this group of patients.


Asunto(s)
Circulación Coronaria/fisiología , Enfermedad Coronaria/fisiopatología , Electrocardiografía , Enfermedad Coronaria/patología , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Índice de Severidad de la Enfermedad , Factores de Tiempo
14.
Angiology ; 58(5): 620-4, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-18024948

RESUMEN

Acute cigarette smoking enhances adrenergic activity and thus may be associated with hemodynamic changes in the cardiovascular system. In this study, the acute effect of cigarette smoking on heart rate variability (HRV) was studied. Fifteen subjects were included in the study. Time domain (the mean R-R interval, the standard deviation of R-R interval, and the root mean square of successive R-R interval differences) and frequency domain (high-frequency, low-frequency ratio, and low-frequency/high-frequency ratio) parameters of HRV were obtained from all participants for each 5-minute segment: 5 minutes before and 5, 10, 15, 20, 25, and 30 minutes after smoking a cigarette. The mean R-R interval, the standard deviation of R-R interval, and the root mean square of successive R-R interval differences significantly decreased within the first 5-minute period compared with baseline, and then the standard deviation of R-R interval increased within the 20- to 30-minute period. The low-frequency high-frequency ratio significantly decreased within the first 5 minutes after smoking and then remained unchanged throughout the study period. Similarly, low-frequency and high-frequency power increased within the first 5 minutes compared with baseline. Acute cigarette smoking alters HRV parameters, particularly within the first 5 to 10 minutes after smoking.


Asunto(s)
Arritmias Cardíacas/etiología , Frecuencia Cardíaca , Fumar/efectos adversos , Fumar/fisiopatología , Adulto , Arritmias Cardíacas/fisiopatología , Estudios de Casos y Controles , Electrocardiografía , Femenino , Humanos , Masculino , Factores de Tiempo
15.
Angiology ; 58(6): 698-703, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-18216379

RESUMEN

Coronary artery ectasia (CAE) is frequently considered as a form of coronary artery disease. Cardiovascular risk factors were determined in a patient population with CAE. The 51 patients with isolated CAE (group 1), 61 patients with CAE coexisting with significant coronary stenosis (group 2), and 62 subjects with significant coronary stenosis (group 3) were included in the study, and the distribution of cardiovascular risk factors was compared. Thirty of 51 patients with isolated CAE had presented with typical angina pectoris, 8 patients with unstable angina pectoris, and 13 patients had atypical chest pain or palpitation. The 21 of 51 patients with isolated CAE had definitive positive treadmill exercise test results. Positive family history was similar in each group. The history of smoking was similar in group 1 and group 2 but higher than group 3. Frequency of hypertension was similar in group 1 and group 2 but higher than that in group 3. Frequency of diabetes mellitus was similar in group 1 and group 2 but lower than group 3. Plasma lipid levels and the number of patients with lipid disturbances were also similar in each group. In addition, C-reactive protein (CRP) levels were above the normal limits and there was no difference among groups with respect to plasma CRP levels. CAE appears to be associated with traditional cardiovascular risk factors such as hypertension, smoking, and hyperlipidemia. In addition, elevated CRP level in patients with CAE may suggest the role of inflammatory process in development of CAE.


Asunto(s)
Aneurisma Coronario/etiología , Estenosis Coronaria/etiología , Vasos Coronarios/patología , Anciano , Proteína C-Reactiva/metabolismo , Aneurisma Coronario/sangre , Aneurisma Coronario/diagnóstico por imagen , Angiografía Coronaria , Estenosis Coronaria/sangre , Estenosis Coronaria/diagnóstico por imagen , Complicaciones de la Diabetes/etiología , Dilatación Patológica , Femenino , Humanos , Hiperlipidemias/complicaciones , Hipertensión/complicaciones , Inflamación/sangre , Inflamación/complicaciones , Masculino , Persona de Mediana Edad , Factores de Riesgo , Fumar/efectos adversos
16.
Am J Hypertens ; 19(4): 361-5, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16580570

RESUMEN

BACKGROUND: Expression of matrix metalloproteinase (MMP) has been shown in aortic dissection and aneurysms indicating increased proteolysis compared with the normal aorta. However, its role in the development of aortic root dilatation has not been studied. We therefore attempted to determine the relationship between aortic root diameter and MMP-9 concentration in a hypertensive population. METHODS: The 53 hypertensive patients with (n = 27) and without aortic dilatation (n = 26) were included in the study. All participants underwent a complete transthoracic echocardiographic examination including aortic root measurement. Plasma concentration of MMP-9 were determined by the one-step sandwich enzyme immunoassay method and compared in both groups. RESULTS: Baseline demographic properties were similar in both groups. No subject had significant valvular disorder and wall motion abnormality on echocardiographic evaluation. On echocardiographic examination only five patients had bicuspid aortic valve. In patients with aortic root dilatation, 21 patients were using an antihypertensive agent, whereas in patients without aortic root dilatation, 19 patients were using an antihypertensive agent. Plasma MMP-9 level was significantly higher in patients with aortic root dilatation than in those without dilatation (2.5 +/- 1.0 v 1.6 +/- 0.9 ng/mL; P = .003). On correlation analysis, we found a positive correlation between aortic diameter and plasma MMM-9 levels (r = 0.43, P = .001). CONCLUSIONS: Aortic root dilatation is associated with higher MMP release, which may indicate the role of increased collagenolytic and elastolytic activities in hypertension-induced aortic root dilatation.


Asunto(s)
Aorta/patología , Aneurisma de la Aorta/sangre , Válvula Aórtica/patología , Hipertensión/fisiopatología , Metaloproteinasa 9 de la Matriz/sangre , Anciano , Aorta/fisiopatología , Aneurisma de la Aorta/patología , Válvula Aórtica/fisiopatología , Biomarcadores/sangre , Dilatación Patológica , Ecocardiografía Doppler en Color , Femenino , Humanos , Hipertensión/sangre , Técnicas para Inmunoenzimas , Masculino , Persona de Mediana Edad
17.
Artículo en Inglés | MEDLINE | ID: mdl-16600454

RESUMEN

Cardiovascular disorders such as decreased heart rate variability, orthostatic hypotension, and arrhythmias have been frequently observed in Parkinson's disease (PD) patients. In this study, authors measured P wave duration and dispersion in PD patients and controls. Twenty-three consecutive patients with idiopathic PD and sex-age matched 23 control subjects were included to the study. A 12-lead surface ECG was obtained from each participant. Maximum-minimum P wave duration and P wave dispersion (PWD) were measured in both groups. Maximum P wave duration was found to be higher in PD patients than controls (117+/-12 vs. 105+/-9 ms p=0.001). Minimum P wave duration was similar in PD patients and controls (64+/-11 vs. 63+/-11 ms p=0.7). PWD in PD patients was also found to be higher than those of controls (53+/-11 vs. 43+/-10 ms p=0.0001). P wave duration and PWD did not significantly differ between PD patients taking anti-parkinsonian agents from those who were not (119+/-13 vs. 116+/-13 ms p=0.4 and 55+/-11 vs. 52+/-11 ms p=0.5, respectively). Moreover, when the PD patients taking anti-parkinsonian agents were excluded from the study, PD patients had still higher P wave duration and PWD compared to controls (119+/-11 vs. 105+/-9 ms p=0.004, 52+/-10 vs. 43+/-10 ms p=0.009, respectively). In conclusion, we found that P wave duration and PWD were greater in PD patients compared to control subjects.


Asunto(s)
Electrocardiografía , Enfermedad de Parkinson/fisiopatología , Anciano , Estudios de Casos y Controles , Distribución de Chi-Cuadrado , Femenino , Humanos , Masculino , Persona de Mediana Edad
18.
Int J Cardiol ; 110(1): 97-9, 2006 Jun 07.
Artículo en Inglés | MEDLINE | ID: mdl-16507322
19.
Tex Heart Inst J ; 33(2): 134-8, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16878613

RESUMEN

Acute effects of smoking on left ventricular function have been studied previously. However, effects on right ventricular function have not yet been investigated. In this study, we attempted to investigate, through a combination of conventional and tissue Doppler imaging (TDI), the acute effects of smoking on both left and right ventricular function in chronic smokers. Thirty chronic smokers (with smoking habits of > or =1 pack/day for 74 +/- 1.3 years) underwent a complete transthoracic echocardiographic examination (2-dimensional, pulsed-wave Doppler transmitral and transtricuspid recordings, and TDI recordings of mitral and tricuspid annular velocities) by 3.5-MHz sector transducer. Pulsed-wave Doppler indices of left and right ventricular diastolic function-such as mitral and tricuspid inflows, peak early (E) and late (A) velocities, and E/A ratios-were obtained by conventional Doppler and TDI. Echocardiographic indices of the left and right ventricles--including isovolumetric relaxation time, isovolumetric contraction time, ejection time, and myocardial performance index of right ventricle-were also measured before and 30 minutes after each subject smoked a cigarette. Both mitral and tricuspid inflow measurements changed significantly after smoking a cigarette. Among the TDI measurements, mitral lateral annulus and tricuspid lateral annulus (diastolic, but not systolic) velocities changed after smoking a cigarette. Also, the right ventricular myocardial performance index increased immediately after smoking a cigarette. We found that acute cigarette smoking impaired both left and right ventricular diastolic function in chronic smokers.


Asunto(s)
Ecocardiografía Doppler de Pulso , Ventrículos Cardíacos/diagnóstico por imagen , Fumar/efectos adversos , Fumar/fisiopatología , Disfunción Ventricular Izquierda/etiología , Disfunción Ventricular Derecha/etiología , Adulto , Velocidad del Flujo Sanguíneo , Femenino , Humanos , Masculino , Válvula Mitral/fisiopatología
20.
Turk Kardiyol Dern Ars ; 44(5): 389-96, 2016 Jul.
Artículo en Turco | MEDLINE | ID: mdl-27439924

RESUMEN

OBJECTIVE: Inflammation is thought to play a role in the pathogenesis of atrial fibrillation. The relationship between CD40 ligand (CD40L), a prothrombotic and proinflammatory molecule, and lone atrial fibrillation was presently investigated for the first time. Levels of serum CD40L were also tested, regarding potential to distinguish patients with lone atrial fibrillation from healthy individuals. METHODS: Presently included were 35 patients with lone persistent atrial fibrillation and a control group of 30 healthy individuals. Serum levels of CD40L and high-sensitive C-reactive protein (hs-CRP) were measured, and transthoracic echocardiography was performed. RESULTS: Mean serum CD40L, hs-CRP, left ventricular end-diastolic diameter, and left atrial diameter values were significantly higher in the group with lone persistent atrial fibrillation than in the control group (7.4±3.5 ng/mL vs 4.3±1.2 ng/mL, p<0.0001; 3.7±1.6 mg/L vs 1.7±0.8 mg/L, p<0.0001; 53.0±4.2 mm vs 46.0±3.8, p<0.0001; 43.5±3.5 mm vs 33.7±3.5, p<0.0001, respectively). Serum CD40L levels were positively correlated with left atrial diameter (r=0.81, p<0.0001) and hs-CRP (r=0.72, p<0.0001). Receiver operating characteristic curve analysis revealed that serum CD40L at the optimal cut-off level of >4.5 ng/mL successfully discriminated patients with lone atrial fibrillation from controls (area under the curve: 0.847; 95% confidence interval: 0.759-0.934; p<0.0001). CONCLUSION: The present findings suggest that CD40L levels play a crucial role in the development of lone atrial fibrillation. In addition, results support that regular clinical follow-up of these patients is necessary, due to increased cardiovascular disease risk, determined by elevated CD40L levels.


Asunto(s)
Fibrilación Atrial/sangre , Fibrilación Atrial/epidemiología , Ligando de CD40/sangre , Adulto , Biomarcadores/sangre , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA